Cardiac tamponade epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Ramyar (talk | contribs)
1,429 edits
No edit summary
Ramyar (talk | contribs)
1,429 edits
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
The cardiac tamponade is most often attributed to the rupture of an acute [[myocardial infarction]] or an intrapericardial rupture of a dissecting ascending [[aortic aneurysm]]. In developed countries malignancy is the leading cause of [[cardiac tamponade]] secondary to [[pericardial effusion]].<ref name="pmid16051963">{{cite journal| author=Gornik HL, Gerhard-Herman M, Beckman JA| title=Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. | journal=J Clin Oncol | year= 2005 | volume= 23 | issue= 22 | pages= 5211-6 | pmid=16051963 | doi=10.1200/JCO.2005.00.745 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16051963  }} </ref><ref name="pmid10554845">{{cite journal| author=Porte HL, Janecki-Delebecq TJ, Finzi L, Métois DG, Millaire A, Wurtz AJ| title=Pericardoscopy for primary management of pericardial effusion in cancer patients. | journal=Eur J Cardiothorac Surg | year= 1999 | volume= 16 | issue= 3 | pages= 287-91 | pmid=10554845 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10554845  }} </ref>
The cardiac tamponade is most often attributed to the rupture of an acute [[myocardial infarction]] or an intrapericardial rupture of a dissecting ascending [[aortic aneurysm]]. In developed countries malignancy is the leading cause of [[cardiac tamponade]] secondary to [[pericardial effusion]].


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*The incidence of cardiac tamponade based on a giant sample size of about 216 million emergency admissions was about 115,638(0.05%)<ref name="urlCARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology">{{cite web |url=http://www.onlinejacc.org/content/71/11_Supplement/A1155 |title=CARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE &#124; JACC: Journal of the American College of Cardiology |format= |work= |accessdate=}}</ref>
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
 
===Prevalence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.


===Case-fatality rate/Mortality rate===
===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*Cardiac temponade mortality rate is significantly different due to its underlying cause.<ref name="pmid10554845">{{cite journal| author=Porte HL, Janecki-Delebecq TJ, Finzi L, Métois DG, Millaire A, Wurtz AJ| title=Pericardoscopy for primary management of pericardial effusion in cancer patients. | journal=Eur J Cardiothorac Surg | year= 1999 | volume= 16 | issue= 3 | pages= 287-91 | pmid=10554845 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10554845  }} </ref><ref name="urlCARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology" />
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
*Overall, hospitalized mortality rate is around 14.3% and sub groups with higher mortality are :
*#Sepsis (odds ratio:3.17)
*#Chest trauma (odds ratio:2.15)
*#Metastatic cancer:(odds ratio:1.90)
*#Acute kidney injury(odds ratio:1.91)
*#Idiopathic pericarditis (odds ratio: 0.21, least cause of mortality)  <br />s


===Age===
===Age===
*Patients of all age groups may develop [disease name].
 
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*The incidence of cardiac tamponade increases with age; the mean age was around 61.9.<ref name="urlCARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology" /><ref name="pmid16051963">{{cite journal| author=Gornik HL, Gerhard-Herman M, Beckman JA| title=Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. | journal=J Clin Oncol | year= 2005 | volume= 23 | issue= 22 | pages= 5211-6 | pmid=16051963 | doi=10.1200/JCO.2005.00.745 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16051963  }} </ref>
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.  
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].


===Race===
===Race===
*There is no racial predilection to [disease name].
*There is no racial predilection to cardiac tamponade.
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
 
===Gender===
===Gender===
*[Disease name] affects men and women equally.
*Cardiac tamponade affects men and women equally.
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
*There is no study suggesting a meaningful sex difference among diagnosed patients.
 
===Region===
*The majority of [disease name] cases are reported in [geographical region].
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].


===Developed Countries===
===Approximate Health Care cost In US===


===Developing Countries===
* It needs around 12 days of hospitalization and a mean cost of $160,397.


==References==
==References==

Revision as of 03:50, 15 January 2020

Cardiac tamponade Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiac Tamponade from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Cardiac tamponade epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Cardiac tamponade epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiac tamponade epidemiology and demographics

CDC on Cardiac tamponade epidemiology and demographics

Cardiac tamponade epidemiology and demographics in the news

Blogs on Cardiac tamponade epidemiology and demographics

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Cardiac tamponade epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]

Overview

The cardiac tamponade is most often attributed to the rupture of an acute myocardial infarction or an intrapericardial rupture of a dissecting ascending aortic aneurysm. In developed countries malignancy is the leading cause of cardiac tamponade secondary to pericardial effusion.

Epidemiology and Demographics

Incidence

  • The incidence of cardiac tamponade based on a giant sample size of about 216 million emergency admissions was about 115,638(0.05%)[1]

Case-fatality rate/Mortality rate

  • Cardiac temponade mortality rate is significantly different due to its underlying cause.[2][1]
  • Overall, hospitalized mortality rate is around 14.3% and sub groups with higher mortality are :
    1. Sepsis (odds ratio:3.17)
    2. Chest trauma (odds ratio:2.15)
    3. Metastatic cancer:(odds ratio:1.90)
    4. Acute kidney injury(odds ratio:1.91)
    5. Idiopathic pericarditis (odds ratio: 0.21, least cause of mortality)
      s

Age

  • The incidence of cardiac tamponade increases with age; the mean age was around 61.9.[1][3]

Race

  • There is no racial predilection to cardiac tamponade.

Gender

  • Cardiac tamponade affects men and women equally.
  • There is no study suggesting a meaningful sex difference among diagnosed patients.

Approximate Health Care cost In US

  • It needs around 12 days of hospitalization and a mean cost of $160,397.

References

  1. ↑ 1.0 1.1 1.2 "CARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology".
  2. ↑ Porte HL, Janecki-Delebecq TJ, Finzi L, Métois DG, Millaire A, Wurtz AJ (1999). "Pericardoscopy for primary management of pericardial effusion in cancer patients". Eur J Cardiothorac Surg. 16 (3): 287–91. PMID 10554845.
  3. ↑ Gornik HL, Gerhard-Herman M, Beckman JA (2005). "Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion". J Clin Oncol. 23 (22): 5211–6. doi:10.1200/JCO.2005.00.745. PMID 16051963.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Cardiac_tamponade_epidemiology_and_demographics&oldid=1595235"